Navigation Links
Ingenious Med's IM Quality Measures(TM) Delivers Insight About Hospitalist Performance
Date:6/10/2008

rtant to that agenda. It's also important that hospitalists have the opportunity to get the same 1.5% PQRI reporting bonus as other specialties. It was nice to be able to call on Ingenious Med and get the data to make our case."

But the value of IM Quality Measures(TM) extends beyond the PQRI. For example, Scottsdale Inpatient Specialists in Scottsdale, Arizona, a rapidly expanding practice, anticipates that documenting outstanding quality measures will lead to enhanced reimbursement by non-government payors.

"We started using IM Quality Measures(TM) because it is the right thing to do from a quality standpoint," explained Scottsdale Inpatient Specialists Medical Director Bruce Waldon, MD, FACP. "A reminder on IM Practice Manager(TM) is a safety net and helps us make sure we do not miss something. Our goal has been to have 100% compliance with the medical core measures and we've hit 100% on all of them since November of 2007."

Waldon thinks the focus on quality will result in enhanced reimbursement from private payors.

"It should help us in the long run," he said. "If we can demonstrate that our outcomes are better and that we reduced re-admissions, we can negotiate better terms with payors. It allows us to say, 'we're saving you money by doing things right and we should get paid for doing the right things.'"

About Ingenious Med: Ingenious Med was founded in 1999 by a group of practicing hospitalist leaders and has a customer base comprising thousands of users in over 500 facilities across the United States. Ingenious Med's flagship product, IM Practice Manager(TM) is an Internet-based application that enables inpatient physicians to capture charges, improve their quality of care, and communicate digitally with their peers and administrators. In addition, the program aggregates management data separately from the hospital information system, so individual physician and total department performance can be accurately evaluated. Natio
'/>"/>

SOURCE Ingenious Med
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM
2. Ingenious Med Reports Record Sales and Client Expansions in 2007
3. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
4. Cardiovascular Meds May Be Beneficial in Alzheimers Disease, According to MedPredict Report
5. Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model
6. Many Americans Share Prescription Meds
7. Breast-Feeding While on Seizure Meds Doesnt Harm Babies
8. Webcast Alert: EP MedSystems Announces EP MedSystems Fourth Quarter 2007 Earnings Conference Call Webcast
9. MedStar Health Unveils Rx for Success Program at Vivien T. Thomas Medical Arts Academy
10. Pregnant Women With Asthma Should Stay on Low Dose of Meds
11. Geriatrician Care Guards Against Risk of Inappropriate Meds
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8FDA Acknowledges Mistakes in Knee Device Approval 58323 1FDA Acknowledges Mistakes in Knee Device Approval 58323 2Brookhaven Labs Joanna Fowler to be awarded National Medal of Science 58320 1Brookhaven Labs Joanna Fowler to be awarded National Medal of Science 58320 2Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 1Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 2